These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 11938455)
21. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535 [TBL] [Abstract][Full Text] [Related]
22. Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases. Eisenthal A; Cameron RB; Uppenkamp I; Rosenberg SA Cancer Res; 1988 Dec; 48(24 Pt 1):7140-5. PubMed ID: 3263900 [TBL] [Abstract][Full Text] [Related]
23. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10]. Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978 [TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088 [TBL] [Abstract][Full Text] [Related]
25. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801 [TBL] [Abstract][Full Text] [Related]
26. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro. Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340 [TBL] [Abstract][Full Text] [Related]
27. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies. Herd ZL Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203 [TBL] [Abstract][Full Text] [Related]
28. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice. Sunkara PS; Bowlin TL; Rosenberger AL; Fleischmann WR J Biol Response Mod; 1989 Apr; 8(2):170-9. PubMed ID: 2499664 [TBL] [Abstract][Full Text] [Related]
29. The influence of Fluosol-DA on the occurrence of lung metastases in Lewis lung carcinoma and B16 melanoma. Teicher BA; Jacobs JL; Kelley MJ Invasion Metastasis; 1988; 8(1):45-56. PubMed ID: 3343092 [TBL] [Abstract][Full Text] [Related]
30. Combined therapy of B16(F10) murine melanoma using E. coli cytosine deaminase gene and murine interleukin-4 gene. Missol-Kolka E; Sochanik A; Szala S Neoplasma; 1998; 45(5):305-11. PubMed ID: 9921920 [TBL] [Abstract][Full Text] [Related]
32. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Pearlstein E; Ambrogio C; Karpatkin S Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304 [TBL] [Abstract][Full Text] [Related]
33. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation. McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655 [TBL] [Abstract][Full Text] [Related]
34. p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment. Zou Y; Tornos C; Qiu X; Lia M; Perez-Soler R Clin Cancer Res; 2007 Aug; 13(16):4900-8. PubMed ID: 17699870 [TBL] [Abstract][Full Text] [Related]
35. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers. Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786 [TBL] [Abstract][Full Text] [Related]
36. Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma. Yockman JW; Kim WJ; Chang CW; Kim SW Gene Ther; 2007 Oct; 14(19):1399-405. PubMed ID: 17653245 [TBL] [Abstract][Full Text] [Related]
37. Anticancer activities of Oldenlandia diffusa. Gupta S; Zhang D; Yi J; Shao J J Herb Pharmacother; 2004; 4(1):21-33. PubMed ID: 15273074 [TBL] [Abstract][Full Text] [Related]
38. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. Da Costa ML; Redmond HP; Bouchier-Hayes DJ J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Esumi N; Fan D; Fidler IJ Cancer Res; 1991 Sep; 51(17):4549-56. PubMed ID: 1873799 [TBL] [Abstract][Full Text] [Related]
40. Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice. Mitrus I; Delić K; Wróbel N; Missol-Kolka E; Szala S Acta Biochim Pol; 2006; 53(2):357-60. PubMed ID: 16733559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]